BridgeMD
New treatment option for Notalgia Paresthetica
Official title High-power Laser Therapy for Notalgia Paresthetica.
ClinicalTrials.gov ID: NCT07356362
What this study is testing
- What it's testing
- A non-invasive modality for the management of neuromusculoskeletal pain conditions that has emerged as a compelling option is high-power laser therapy (HPLT). The pathophysiology of notalgia paresthetica (NP) is treated uniquely by HPLT, which targets both the presumed muscular component of nerve entrapment and the resultant neuropathic symptoms.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Adults aged 18-75 years
- Clinical diagnosis of unilateral Notalgia Paresthetica for at least 3 months
- Presence of characteristic symptoms (pruritus, paresthesia, and/or burning pain) in the typical T2-T6 dermatomal distribution
- A minimum score of 4 on the Numeric Rating Scale (NRS) for pruritus intensity
- Presence of hyperpigmentation in the affected area
You likely can't join if
- \- Secondary causes of symptoms (e.g., spinal pathology, herpes zoster, renal failure)
- Previous spinal surgery in the thoracic region
- Coagulopathy or use of anticoagulant medication
- Skin diseases or infections in the treatment area
- Pregnancy or lactation
- Cognitive impairment affecting ability to complete questionnaires
See the full eligibility criteria
- Adults aged 18-75 years
- Clinical diagnosis of unilateral Notalgia Paresthetica for at least 3 months
- Presence of characteristic symptoms (pruritus, paresthesia, and/or burning pain) in the typical T2-T6 dermatomal distribution
- A minimum score of 4 on the Numeric Rating Scale (NRS) for pruritus intensity
- Presence of hyperpigmentation in the affected area
- \- Secondary causes of symptoms (e.g., spinal pathology, herpes zoster, renal failure)
- Previous spinal surgery in the thoracic region
- Coagulopathy or use of anticoagulant medication
- Skin diseases or infections in the treatment area
- Pregnancy or lactation
- Cognitive impairment affecting ability to complete questionnaires
- Previous treatment with botulinum toxin in the affected area within 6 months
The study team makes the final eligibility decision.
Where it's taking place
- Uşak, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Uşak, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.